Learn More
Apexbio Technology LLC Vandetanib (ZD6474) 443913-73-3 100mg

Supplier: Apexbio Technology LLC A8555100
Vandetanib (ZD6474 CAS 443913-73-3) is a small molecule inhibitor targeting both vascular endothelial growth factor receptor 2 (VEGFR-2) and epidermal growth factor receptor (EGFR) tyrosine kinases with IC50 values of 40 nM and 500 nM respectively In biochemical assays vandetanib displays stronger inhibitory activity toward VEGFR-2 compared to VEGFR-3 and VEGFR-1 In human umbilical vein endothelial cells it suppresses VEGF- and EGF-induced proliferation with IC50 values of 60 nM and 170 nM respectively Vandetanib has been shown to inhibit the growth of various cancer cell lines and to reduce tumor progression in xenograft models supporting its utility in studies of angiogenesis and targeted cancer therapies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.